Pharma Equity Group A/S

PEG.CO · CPH
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market CapDKK 202,987DKK 464,555DKK 15,291DKK 22,785
- CashDKK 1,544DKK 4,231DKK 182DKK 0
+ DebtDKK 11,045DKK 30,221DKK 22,841DKK 18,925
Enterprise ValueDKK 212,488DKK 490,545DKK 37,950DKK 41,710
RevenueDKK 0DKK 0DKK 0DKK 0
% Growth
Gross Profit-DKK 235-DKK 480DKK 0DKK 0
% Margin
EBITDA-DKK 21,038-DKK 24,799DKK 4,475DKK 6,056
% Margin
Net Income-DKK 24,422-DKK 24,609DKK 3,479DKK 5,392
% Margin
EPS Diluted-0.023-0.0230.0780.097
% Growth-0.4%-129.1%-19.2%
Operating Cash Flow-DKK 22,861-DKK 16,624-DKK 2,874-DKK 2,089
Capital ExpendituresDKK 0-DKK 73DKK 0DKK 0
Free Cash Flow-DKK 22,861-DKK 16,697-DKK 2,874-DKK 2,089
Pharma Equity Group A/S (PEG.CO) Financial Statements & Key Stats | AlphaPilot